News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT Michael O'Riordan May 28, 2024
News Conference News EuroPCR 2023 ‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise Michael O'Riordan May 18, 2023
News Conference News EuroPCR 2023 BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction Michael O'Riordan May 16, 2023
News Conference News EuroPCR 2022 Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities Caitlin E. Cox May 25, 2022
News Conference News EuroPCR 2022 Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT Yael L. Maxwell May 17, 2022
News Conference News EuroPCR 2021 Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate Caitlin E. Cox May 24, 2021
News Conference News EuroPCR 2021 FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold Michael O'Riordan May 19, 2021
News Conference News EuroPCR 2021 The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages L.A. McKeown May 19, 2021
News Conference News EuroPCR 2020 DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions Todd Neale June 30, 2020
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019
News Conference News EuroPCR 2019 EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal L.A. McKeown May 23, 2019
News Conference News EuroPCR 2019 Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers Caitlin E. Cox May 23, 2019
News Conference News EuroPCR 2019 Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years Caitlin E. Cox May 21, 2019
News Conference News EuroPCR 2018 DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis Caitlin E. Cox May 30, 2018
News Conference News EuroPCR 2018 Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study Michael O'Riordan May 29, 2018
Presentation EuroPCR 2018 TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent Presenter: Andreas Baumbach May 25, 2018
News Conference News EuroPCR 2018 New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes Michael O'Riordan May 25, 2018
News Conference News EuroPCR 2018 Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents Shelley Wood May 24, 2018
News Features EuroPCR 2017 Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles Yael L. Maxwell June 01, 2017
News Conference News EuroPCR 2017 Slimmest Stent to Date Looks Promising in Small Study Shelley Wood May 19, 2017